Claire Fleming
16th Lorne Infection and Immunity 2026
Days
Wednesday, 18th February
Thursday, 19th February
Friday, 20th February
Tracks
Adaptive Immunity
Advances in Treatment for Infectious Diseases
Emerging Infectious Disease Threats (and/or Antimicrobial Resistance)
Host-Pathogen Interactions
Innate Immunity
Microbiota and Mucosal Infections
Molecular Basis of Infectious Diseases
Search
Speakers
Claire Fleming
Abstracts this author is presenting:
The IL-33/ST2 signaling axis activates pulmonary ILC2s in SARS-CoV-2 infection and enhances COVID-19 disease severity
—
Session 3: Host-Pathogen Interactions